# Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face

> **NCT04210258** · — · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 154 (actual)

## Conditions studied

- Correction of Facial Wrinkles/Folds
- Facial Volume Enhancement

## Interventions

- **DEVICE:** Etermis 3
- **DEVICE:** Etermis 4

## Key facts

- **NCT ID:** NCT04210258
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-01
- **Primary completion:** 2017-12-27
- **Final completion:** 2017-12-27
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2020-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04210258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04210258, "Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04210258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*